Glycobiology of AIDS

Carbohydrates in Chemistry and Biology

Volumn 4-4, Issue , 2008, Pages 851-866

  Feizi, Ten ^a  

^a MRC Clinical Research Centre   (United Kingdom)

Author keywords

Anomerization; Mannopyranose; Mannosidosis; Oligosaccharides; Phosphomannans

Indexed keywords

ANIMALS; ANTIBODIES; CHAINS; GLYCOPROTEINS; OLIGOSACCHARIDES; ONCOGENIC VIRUSES;

ANOMERIZATION; ENVELOPE GLYCOPROTEINS; GLYCOSYLATED; HORIZONTAL TRANSMISSIONS; MANNOPYRANOSE; MANNOSIDOSIS; PHOSPHOMANNANS; VIRAL INFECTIONS;

DISEASES;

EID: 84956488706     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527618255.ch91     Document Type: Chapter

References (76)

1. T. Feizi, M. Larkin, AIDS and glycosylation. Glycobiology 1990, 1, 17-23.
2. H. Geyer, and R. Geyer, Glycobiology in Viruses. Curr. Biol. 1999, in press.
3. A. Otteken, B. Moss, Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. J. Biol. Chem. 1996, 271, 97-103.
4. A. Mehta, N. Zitzmann, P. M. Rudd, T. M. Block, R. A. Dwek, Alpha-glucosidase inhibitors as potential broad based anti-viral agents. FEBS Lett. 1998, 430, 17-22.
5. H. Geyer, C. Holschbach, G. Hunsmann, J. Schneider, Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 1988, 265, 11760-11767.
6. T. Mizuochi, T. J. Matthews, M. Kato, J. Hamako, K. Titani, J. C. Solomon, T. Feizi, Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. J. Biol. Chem. 1990, 265, 8519-8524.
7. T. Mizuochi, M. W. Spellman, M. Larkin, J. C. Solomon, L. J. Basa, T. Feizi, Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem. J. 1988, 254, 599-603.
8. S. Liedtke, M. Adamski, R. Geyer, A. Pfutzner, W. H. Rubsamen, H. Geyer, Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates. Glycobiology 1994, 4, 477-484.
9. S. Liedtke, R. Geyer, H. Geyer, Host-cell-specific glycosylation of HIV-2 envelope glycoprotein. Glycoconj. J. 1997, 14, 785-793.
10. J. C. Yeh, J. R. Seals, C. I. Murphy, H. van Halbeek, R. D. Cummings, Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system. Biochemistry 1993, 32, 11087-11099.
11. T. D. Butters, B. Yudkin, G. S. Jacob, I. M. Jones, Structural characterization of the N-linked oligosaccharides derived from HIVgp120 expressed in lepidopteran cells. Glycoconj. J. 1998, 15, 83-88.
12. A. Shilatifard, R. K. Merkle, D. E. Heiland, J. L. Welles, W. A. Haseltine, R. D. Cummings, Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine. J. Virol. 1993, 67, 943-952.
13. A. Bolmstedt, M. Biller, J. E. Hansen, J. P. Moore, S. Olofsson, Demonstration of peripheral fucose units in N-linked glycans of human immunodeficiency virus type 1 gp 120: effects on glycoprotein conformation. Arch. Virol. 1997, 142, 2465-2481.
14. T. Feizi, H. C. Gooi, R. A. Childs, J. K. Picard, K. Uemura, L. M. Loomes, S. J. Thorpe, E. F. Hounsell, Tumour-associated and differentiation antigens on the carbohydrate moieties of mucin-type glycoproteins. Biochem. Soc. Trans. 1984, 12, 591-596.
15. B. S. Stein, E. G. Engleman, Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J. Biol. Chem. 1990, 265, 2640-2649.
16. R. K. Merkle, D. E. Helland, J. L. Welles, A. Shilatifard, W. A. Haseltine, R. D. Cummings, gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing. Arch. Biochem. Biophys. 1991, 290, 248-257.
17. J. E. Hansen, H. Clausen, S. L. Hu, J. O. Nielsen, S. Olofsson, An O-linked carbohydrate neutralization epitope of HIV-1 gp 120 is expressed by HIV-1 env gene recombinant vaccinia virus. Arch. Virol. 1992, 126, 11-20.
18. J. E. Hansen, C. Nielsen, M. Arendrup, S. Olofsson, L. Mathiesen, J. O. Nielsen, H. Clausen, Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J. Virol. 1991, 65, 6461-6467.
19. J.-E.S. Hansen, H. Clausen, C. Nielsen, L.S. Teglbjaerg, L.L. Hansen, C.M. Nielsen, E. Dabelsteen, L. Mathiesen, S.-I. Hakomori, J.O. Nielsen, Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glyco sylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J. Virol. 1990, 64, 2833-2840.
20. M. Larkin, W. Knapp, M. S. Stoll, H. Mehmet, T. Feizi, Monoclonal antibodies VIB-E3, IB5 and HB9 to the leucocyte/epithelial antigen CD24 resemble BA-1 in recognizing sialic acid-dependent epitope(s). Evidence that VIB-E3 recognizes NeuAcα2-6Gal sequences. Clin. Exp. Immunol. 1991, 85, 536-541.
21. J. E. Hansen, B. Jansson, G. J. Gram, H. Clausen, J. O. Nielsen, S. Olofsson, Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop. Arch. Virol. 1996, 141, 291-300.
22. H. Clausen, E. P. Bennett, A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. Glycobiology 1996, 6, 635-646.
23. W. R. Lee, W. J. Syu, B. Du, M. Matsuda, S. Tan, A. Wolf, M. Essex, T. H. Lee, Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. U.S.A. 1992, 89, 2213-2217.
24. W. R. Lee, X. F. Yu, W. J. Syu, M. Essex, T. H. Lee, Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41. J Virol. 1992, 66, 1799-1803.
25. D. A. Dedera, R. L. Gu, L. Ratner, Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function. Virology 1992, 187, 377-382.
26. E. Fenouillet, I. Jones, B. Powell, D. Schmitt, M. P. Kieny, J. C. Gluckman, Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain. J. Virol. 1993, 67, 150-160.
27. E. Fenouillet, J. C. Gluckman, I. M. Jones, Functions of HIV envelope glycans. Trends Biochem. Sci. 1994, 19, 65-70.
28. E. Fenouillet, I. M. Jones, The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J. Gen. Virol. 1995, 76, 1509-1514.
29. C. Perrin, E. Fenouillet, I. M. Jones, Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein. Virology 1998, 242, 338-345.
30. T. Feizi, Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 1985, 314, 53-57.
31. T. Feizi, R. A. Childs, Carbohydrates as antigenic determinants of glycoproteins. Biochem. J. 1987, 245, 1-11.
32. T. Feizi, The blood group Ii system: a carbohydrate antigen system defined by naturally monoclonal or oligoclonal autoantibodies of man. Immunol. Commun. 1981, 10, 127-156.
33. D. Davis, D. M. Stephens, C. Willers, P. J. Lachmann, Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1. J. Gen. Virol. 1990, 71, 2889-2898.
34. J. J. Skehel, D. J. Stevens, R. S. Daniels, A. R. Douglas, M. Knossow, I. A. Wilson, D. C. Wiley, A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl Acad. Sci. U.S.A 1984, 81, 1779-1783.
35. B. Chackerian, L. M. Rudensey, J. Overbaugh, Specific N-linked and O-linked glycosylation modifications in the envelope VI domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 1997, 71, 7719-7727.
36. A. Benjouad, J. C. Gluckman, H. Rochat, L. Montagnier, E. Bahraoui, Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J. Virol. 1992, 66, 2473-2483.
37. R. Wyatt, P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, J. G. Sodroski, The antigenic structure of the HIV gp120 envelope glycoprotein [see comments]. Nature 1998, 393, 705-711.
38. R. Wyatt, J. Sodroski, The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 250, 1884-1888.
39. P. Botarelli, B. A. Houlden, N. L. Haigwood, C. Servis, D. Montagna, S. Abrignani, N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J Immunol. 1991, 147, 3128-3132.
40. F. Manca, Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells. J Immunol. 1992, 148, 2278-2282.
41. J. Favero, Lectins in AIDS research. Glycobiology 1994, 4, 387-396.
42. L. Gattegno, A. Ramdani, T. Jouault, L. Saffar, J. C. Gluckman, Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1). AIDS Res. Hum. Retroviruses 1992, 8, 27-37.
43. O. Andersen, A. M. Sorensen, S. E. Svehag, E. Fenouillet, Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4. Scand. J. Immunol. 1991, 33, 81-88.
44. R. W. Loveless, T. Feizi, R. A. Childs, T. Mizuochi, M. S. Stoll, Oldroyd R.G., P. J. Lachmann, Bovine serum conglutinin is a lectin which binds non-reducing terminal N-acetylglucosamine, mannose and fucose residues. Biochem. J. 1989, 258, 109-113.
45. T. Mizuochi, R. W. Loveless, A. M. Lawson, W. Chai, P. J. Lachmann, R. A. Childs, S. Thiel, T. Feizi, A library of oligosaccharide probes (neoglycolipids) from N-glycosylated proteins reveals that conglutinin binds to certain complex type as well as high-mannose type oligosaccharide chains. J. Biol. Chem. 1989, 264, 13834-13839.
46. T. Tomiyama, D. Lake, Y. Masuho, E. M. Hersh, Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochem. Biophys. Res. Commun. 1991, 177, 279-285.
47. W. E. Muller, M. Bachmann, B. E. Weiler, H. C. Schroder, G. Uhlenbruck, T. Shinoda, H. Shimizu, H. Ushijima, Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro. J. Acquir. Immun. Defic. Syndr. 1991, 4, 694-703.
48. M. Arendrup, J. E. Hansen, H. Clausen, C. Nielsen, L. R. Mathiesen, J. O. Nielsen, Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors. AIDS 1991, 5, 441-444.
49. K. Abe, S. B. Levery, S. Hakomori, The antibody specific to Type 1 chain blood group A determinant. J. Immunol. 1984, 132, 1951-1954.
50. W. M. Watkins, Biochemistry and genetics of the ABO, Lewis and P blood group systems. Adv. Hum. Gen. 1980, 10, 1-136, 379-385.
51. R. P. Rother, W. L. Fodor, J. P. Springhorn, C. W. Birks, E. Setter, M. S. Sandrin, S. P. Squinto, S. A. Rollins, A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J. Exp. Med. 1995, 182, 1345-1355.
52. H. Geyer, R. Kempf, H. H. Schott, R. Geyer, Glycosylation of the envelope glycoprotein from a polytropic murine retrovirus in two different host cells. Eur. J. Biochem. 1990, 193, 855-862.
53. U. Galili, S. B. Shohet, E. Kobrin, C. L. Stults, B. A. Macher, Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J. Biol. Chem. 1988, 263, 17755-17762.
54. Y. Takeuchi, C. D. Porter, K. M. Strahan, A. F. Preece, K. Gustafsson, F. L. Cosset, R. A. Weiss, M. K. Collins, Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. Nature 1996, 379, 85-88.
55. C. Patience, Y. Takeuchi, R. A. Weiss, Infection of human cells by an endogenous retrovirus of pigs [see comments]. Nat. Med. 1997, 3, 282-286.
56. S. Hakomori, Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 1985, 45, 2405-2414.
57. J. E. Hansen, C. Nielsen, H. Clausen, L. R. Mathiesen, J. O. Nielsen, Effect of anti-carbohydrate antibodies on HIV infection in a monocytic cell line (U937). Antiviral Res. 1991, 16, 233-242.
58. S. S. Hwang, T. J. Boyle, H. K. Lyerly, B. R. Cullen, Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253, 71-74.
59. W. A. O'Brien, Y. Koyanagi, A. Namazie, J. Q. Zhao, A. Diagne, K. Idler, J. A. Zack, I. S. Chen, HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990, 348, 69-73.
60. T. Shioda, J. A. Levy, M. C. Cheng, Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991, 349, 167-169.
61. P. Westervelt, H. E. Gendelman, L. Ratner, Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl Acad. Sci. U.S.A. 1991, 88, 3097-3101.
62. N. E. Sharpless, W. A. O'Brien, E. Verdin, C. V. Kufta, I. S. Chen, D. M. Dubois, Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J. Virol. 1992, 66, 2588-2593.
63. P. Westervelt, D. B. Trowbridge, L. G. Epstein, B. M. Blumberg, Y. Li, B. H. Hahn, G. M. Shaw, R. W. Price, L. Ratner, Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 1992, 66, 2577-2582.
64. M. Larkin, R. A. Childs, T. J. Matthews, S. Thiel, T. Mizuochi, A. M. Lawson, J. S. Savill, C. Haslett, R. Diaz, T. Feizi, Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. AIDS 1989, 3, 793-798.
65. P. D. Stahl, J. S. Rodman, M. J. Miller, P. H. Schlessinger, Evidence for receptor-mediated binding of glycoproteins, glycoconjugates and lysosomal glycosidases by alveolar macrophages. Proc. Natl Acad. Sci. U.S.A. 1978, 75, 1399-1403.
66. V. L. Shepherd, Y. C. Lee, P. H. Schlesinger, P. D. Stahl, L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages. Proc. Natl Acad. Sci. USA 1981, 78, 1019-1022.
67. T. Feizi, Cell-cell adhesion and membrane glycosylation. Curr. Opin. Struct. Biol. 1991, 1, 766-770.
68. D. Solis, T. Feizi, C. T. Yuen, A. M. Lawson, R. A. Harrison, R. W. Loveless, Differential recognition by conglutinin and mannan-binding protein of N -glycans presented on neo-glycolipids and glycoproteins with special reference to complement glycoprotein C3 and ribonuclease B. J. Biol. Chem. 1994, 269, 11555-11562.
69. A. Lafeuillade, M. C. Alessi, M. Poizot, N. C. Boyer, C. Zandotti, R. Quilichini, L. Aubert, C. Tamalet, V. Juhan, I, J. A. Gastaut, Endothelial cell dysfunction in HIV infection. J. Acquir. Immun. Defic. Syndr. 1992, 5, 127-131.
70. S. D. Rosen, C. R. Bertozzi, Leukocyte adhesion: Two selectins converge on sulphate. Curr. Biol. 1996, 6, 261-264.
71. P. R. Crocker, T. Feizi, Carbohydrate recognition systems: functional triads in cell-cell interactions. Curr. Opin. Struct. Biol. 1996, 6, 679-691.
72. D. Vestweber, J. E. Blanks, Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 1999, 79, 181-213.
73. L. J. Picker, T. K. Kishimoto, W. C. Smith, R. A. Warnock, E. C. Butcher, ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991, 349, 796-799.
74. Y. Shimizu, S. Shaw, N. Graber, K. J. Horgan, G. A. Van Seventer, W. Newman, Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature 1991, 349, 799-802.
75. F. Miedema, M. Tersmette, R. A. W. Van Lier, AIDS pathogenesis: a dynamic interaction betwwen HIV and the immune system. Immunol. Today 1990, 11, 293-297.
76. D. Solís, M. Bruix, L. González, T. Díaz-Mauriño, M. Rico, J. Jiménez-Barbero, T. Feizi, Carrier protein-modulated recognition of Mans N-glycan by the carbohydrate-binding protein. (Submitted for publication).